Statistics
Total Visits
Views | |
---|---|
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer(legacy) | 137 |
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer(legacy) | 101 |
Total Visits per Month
November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
---|---|---|---|---|---|---|---|
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer | 6 | 4 | 8 | 0 | 8 | 7 | 9 |
File Downloads
Views |
---|
Top Country Views
Views | |
---|---|
United States | 61 |
China | 35 |
Australia | 9 |
Netherlands | 8 |
France | 7 |
Vietnam | 6 |
Singapore | 4 |
Germany | 2 |
United Kingdom | 2 |
Argentina | 1 |
Top City Views
Views | |
---|---|
Beijing | 22 |
Ashburn | 20 |
Rotterdam | 8 |
Kaleen | 7 |
Hanoi | 6 |
Zhengzhou | 6 |
Fairfield | 4 |
Cambridge | 3 |
Boardman | 2 |
Dearborn | 2 |